VOZOL Unveils UK Debut of Open-Pod Ace Max with 'Largest HD Touch Screen'

Market by 2FIRSTS.ai
Dec.13.2024
VOZOL Unveils UK Debut of Open-Pod Ace Max with 'Largest HD Touch Screen'
VOZOL introduces new open system e-cigarette, Ace Max, featuring world's largest HD touch screen, now available in UK.

Special announcement:

This article is intended for internal industry communication only and does not make any recommendations for brands or products.

The images presented in this article are used solely to depict factual information and are not intended as advertisements for any products.

This article prohibits access for minors.


Recently, it has come to the attention of 2Firsts that the well-known e-cigarette brand VOZOL has launched a new open system, the VOZOL Ace Max, on its official website. The brand's promotion claims that this product features "the world's largest high-definition touch screen." Currently, the VOZOL Ace Max is available on the websites of e-cigarette distributors in the UK, such as vapesuperstore and ideavape.

 

VOZOL official website showcases its first open system product

 

VOZOL Unveils UK Debut of Open-Pod Ace Max with 'Largest HD Touch Screen'
VOZOL Ace Max | Image Source: VOZOL Official Website

 

Specifically, the product features of VOZOL Ace Max are as follows:

 

VOZOL Unveils UK Debut of Open-Pod Ace Max with 'Largest HD Touch Screen'
VOZOL Ace Max product specifications | Graphic: 2Firsts

 

According to the information posted on the official website of the VOZOL brand, VOZOL Ace Max is the only open system product showcased by the brand. It belongs to the "ACE" product series and its main feature is the 1.47-inch touch screen display, which shows data including power, inhalation count, and battery level.

 

The only e-liquid product displayed on the VOZOL official website

 

On the official website for VOZOL Ace Max, the "Product Recommendations" section displays an e-liquid product available in two nicotine concentrations, 20mg and 50mg, and two sizes, 10ml and 30ml. The brand also offers a variety of 60 different flavors for consumers to choose from.

 

VOZOL Unveils UK Debut of Open-Pod Ace Max with 'Largest HD Touch Screen'
VOZOL E-liquid | Image source: VOZOL official website

 

This e-liquid is currently the only e-liquid product displayed on the official website of the VOZOL brand.

 

It is reported that VOZOL Ace Max was officially launched on the official website of VOZOL in November this year. Currently, the product is available on e-cigarette distributor websites such as vapesuperstore and ideavape in the UK, with a selling price of around £29.99.

 

VOZOL Unveils UK Debut of Open-Pod Ace Max with 'Largest HD Touch Screen'
VOZOL Ace Max real picture | Image source: ideavape

 

2Firsts discovered through online e-cigarette retailers such as vapesourcing, vapeclub, zerovapes, that the VOZOL brand mainly sells disposable e-cigarettes and a few pod systems. As of the time of writing, there have been no other open system products from the VOZOL brand except for the VOZOL Ace Max.

 

2Firsts will continue to monitor the performance and market trends of e-cigarette products globally, providing the public with accurate and authoritative industry information.

 


The product section focuses on providing readers with the latest information in the tobacco industry, welcoming submissions from readers to share the newest products in the e-cigarette field.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

JTI Proposes 25-Cent Irish Cigarette Tax Increase, Says It Could Raise €45 Million
JTI Proposes 25-Cent Irish Cigarette Tax Increase, Says It Could Raise €45 Million
Japan Tobacco International's Irish business has proposed a €0.25 tax increase on a pack of 20 cigarettes in its pre-Budget 2027 submission, below the €0.50-or-more increases typically imposed in recent Irish budgets. JTI says the proposal could generate around €45 million in additional Exchequer revenue while limiting further movement toward illicit and non-Irish-tax-paid tobacco. Revenue's existing estimate for a comparable €0.25 increase, including pro-rata rises on other tobacco products, is about €18 million for a full year.
JTI
Sep.18 by 2Firsts Perspectives
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
A commentary published in the international open-access, peer-reviewed Harm Reduction Journal argues that randomized controlled trials remain central to evaluating smoking cessation efficacy but cannot alone capture real-world uptake, complete switching, longer-term use and population impact of non-combustible nicotine products such as e-cigarettes, heated tobacco and nicotine pouches. The authors frame impact as “reach × efficacy” and call for real-world evidence to complement RCTs. Three days after publication, the FDA authorized three JUUL2 products and highlighted complete switching among adult smokers in explaining its decision, providing a timely regulatory backdrop to the debate.
Sep.08
Australia-China Operation Dismantles Tobacco Smuggling Network: 112 Containers, 60 Arrests and A$92 Million in Illicit Tobacco
Australia-China Operation Dismantles Tobacco Smuggling Network: 112 Containers, 60 Arrests and A$92 Million in Illicit Tobacco
According to The Maritime Executive on August 19, 2026, the Australian Border Force (ABF) and China’s Anti-Smuggling Bureau of General Administration of China Customs worked together to dismantle an international illicit tobacco smuggling network targeting Australia. According to information released by ABF on August 20, sustained information sharing and cooperation led to investigations into 112 shipping containers, with 91 found to contain illicit tobacco. Authorities seized more than 60 million cigarettes and 60 kilograms of loose-leaf tobacco, representing more than A$92 million in unpaid duties. More than 60 people suspected of involvement in the network were arrested in China.
Aug.20
InterTabac 2026: Further Sessions on Regulation, Market Access and Innovation Confirmed; 2FIRSTS to Host China Market Forum
InterTabac 2026: Further Sessions on Regulation, Market Access and Innovation Confirmed; 2FIRSTS to Host China Market Forum
InterTabac 2026 will bring together international experts to discuss European regulation, tax policy, Track & Trace, market access, retail impacts, consumer behavior and innovation. Sessions will also examine Poland’s tobacco-growing perspective and the growing fragmentation of Europe’s tobacco and nicotine market. Media partner 2FIRSTS will host the second “2FIRSTS Connect at InterTabac” on September 16, focusing on developments in China’s tobacco and nicotine industry.
Aug.06
U.S. Fifth Circuit Vacates NicQuid Vape MDO, Says FDA Comparative-Efficacy Standard Violated APA Procedures
U.S. Fifth Circuit Vacates NicQuid Vape MDO, Says FDA Comparative-Efficacy Standard Violated APA Procedures
According to VitalLaw on August 27, 2026, the U.S. Court of Appeals for the Fifth Circuit vacated an FDA marketing denial order (MDO) against NicQuid LLC, ruling that the agency’s comparative-efficacy standard for electronic nicotine delivery system (ENDS) applications had become a substantive rule requiring notice-and-comment rulemaking under the Administrative Procedure Act (APA). The court did not reject FDA’s authority to compare the public health benefits and risks of flavored vapes, but held that the agency could not establish a broadly binding standard through informal adjudications. The case was remanded to FDA for further proceedings.
Aug.28
FDA Authorizes Four More Nicotine Pouches as Review Pilot Expands Beyond Initial Decisions
FDA Authorizes Four More Nicotine Pouches as Review Pilot Expands Beyond Initial Decisions
The FDA has authorized four additional on! nicotine pouches, bringing the U.S. total to 30. The decision marks another outcome of the agency’s nicotine pouch review pilot, whose communication and review practices are now being applied more broadly across the category. It also extends Helix’s authorized portfolio from on! PLUS to the earlier on! line. Yet all FDA-authorized nicotine pouches still come from subsidiaries of PMI or Altria, underscoring how concentrated U.S. regulatory access remains.
Aug.05